2026 NPPES data Neuromusculoskeletal Medicine & OMM Physician NPI 1275073215 MS, MPH, DO
Verify on CMS →

ELIZABETH BALYAKINA, MS, MPH, DO

Neuromusculoskeletal Medicine & OMM Physician in SAN ANTONIO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 351 beneficiaries · Neuromusculoskeletal Medicine & OMM Physician avg: 1K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.9223/100
▲ 7 pts above national avg 83.1 · [object Object]

What the federal data shows

ELIZABETH BALYAKINA, MS, MPH, DO reported a CMS MIPS final score of 89.9223/100 — above the 83.1 national average — and filed 4,122 Medicare Part D claims in 2023.

89.9223/100
MIPS score · +7 vs avg
4K
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ELIZABETH BALYAKINA, MS, MPH, DO's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ELIZABETH BALYAKINA, MS, MPH, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ELIZABETH BALYAKINA, MS, MPH, DO?

High performer (top quartile)

NPI registry status

Active

Issued 02/23/2017

NPI 1275073215

Primary specialty

Neuromusculoskeletal Medicine & OMM Physician

Niche

1,235 US NPIs in this specialty

Medicare Part D claims

4,122 272% vs specialty avg

2023 prescription claims

Specialty avg: 1,107

MIPS final score

89.9223/100 6.822300000000013% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Neuromusculoskeletal Medicine & OMM Physician compares to other specialties among Texas providers

Texas providers

Neuromusculoskeletal Medicine & OMM Physician share within Texas

1. Neuromusculoskeletal Medicine & OMM Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuromusculoskeletal Medicine & OMM Physician share within Texas

Medicare quality performance — MIPS

ELIZABETH BALYAKINA, MS, MPH, DO's 2023 MIPS final score plotted against the Neuromusculoskeletal Medicine & OMM Physician national average

High performer (top quartile)
MIPS Final Score
89.9223/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neuromusculoskeletal Medicine & OMM Physician) — 89.9223/100 vs national avg 83.1

0%100%National avg83%89.9%
MIPS final score (Neuromusculoskeletal Medicine & OMM Physician) — 89.9223/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ELIZABETH BALYAKINA, MS, MPH, DO appears in the CMS NPPES registry as a Neuromusculoskeletal Medicine & OMM Physician provider holding MS, MPH, DO credentials at 1055 ADA ST, SAN ANTONIO, TX, 78223, with a listed phone of (210) 358-5515. NPI 1275073215 was issued on 02/23/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BALYAKINA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,122 prescription claims written by this provider, covering 351 Medicare beneficiaries and totaling roughly $718K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 0.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.9223/100 for the 2023 performance year (Quality 79.3908, Cost 62.898), compared with the national average of 83.1.

Neuromusculoskeletal Medicine & OMM Physician is a narrow specialty nationwide, with 1,235 enrolled providers across 51 states and an average of 1,107 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1055 ADA ST
SAN ANTONIO, TX 78223

Provider Details

NPI 1275073215
Specialty Neuromusculoskeletal Medicine & OMM Physician
Credentials MS, MPH, DO
Gender Female
NPI Issued 02/23/2017

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.9223
Final Score
Avg: 83.1
79.3908
Quality
62.898
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ELIZABETH BALYAKINA, MS, MPH, DO bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COMMUNITY MEDICINE ASSOCIATES
SAN ANTONIO, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to ELIZABETH BALYAKINA, MS, MPH, DO. To verify ELIZABETH BALYAKINA, MS, MPH, DO's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ELIZABETH BALYAKINA, MS, MPH, DO — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 4,122 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,122
Total Claims
$718K
Total Drug Cost
351
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,587
Total Day Supply
249,269
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$626K
Generic Drug Cost
$89K
Opioid Claims
15 (0.4% rate)
Antibiotic Claims
65

Patient Demographics

Average Patient Age
65.3 years
Avg HCC Risk Score
1.79
Gender Split
71% female / 29% male
Age Distribution
<65: 126, 65-74: 168, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ELIZABETH BALYAKINA, MS, MPH, DO prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
212
Fluticasone Propionate
208
Gabapentin
140
Amlodipine Besylate
123
Montelukast Sodium
120
Lisinopril
118
Albuterol Sulfate Hfa
Albuterol Sulfate
108
Metformin Hcl
99
Rosuvastatin Calcium
98
Losartan Potassium
94

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuromusculoskeletal Medicine & OMM Physician Overview

How ELIZABETH BALYAKINA, MS, MPH, DO fits within the Neuromusculoskeletal Medicine & OMM Physician landscape nationally.

1,235
Neuromusculoskeletal Medicine & OMM Physician Providers in US
51
States with Neuromusculoskeletal Medicine & OMM Physician
1,107
Avg Claims per Provider

ELIZABETH BALYAKINA, MS, MPH, DO's 4,122 claims are above the specialty average of 1,107.

Nearby Neuromusculoskeletal Medicine & OMM Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BALYAKINA.

Compare Neuromusculoskeletal Medicine & OMM Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ELIZABETH BALYAKINA, MS, MPH, DO's specialty?
ELIZABETH BALYAKINA, MS, MPH, DO specializes in Neuromusculoskeletal Medicine & OMM Physician and practices in SAN ANTONIO, Texas. Credentials: MS, MPH, DO.
How much does ELIZABETH BALYAKINA, MS, MPH, DO prescribe under Medicare Part D?
In 2023, ELIZABETH BALYAKINA, MS, MPH, DO wrote 4,122 Medicare Part D claims totaling $718K in drug costs for 351 beneficiaries.
What is ELIZABETH BALYAKINA, MS, MPH, DO's Medicare quality score?
ELIZABETH BALYAKINA, MS, MPH, DO has a CMS MIPS Final Score of 89.9223/100 (Quality: 79.3908, Cost: 62.898). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ELIZABETH BALYAKINA, MS, MPH, DO located?
ELIZABETH BALYAKINA, MS, MPH, DO is located at 1055 ADA ST, SAN ANTONIO, TX, 78223. Phone: (210) 358-5515.
What is ELIZABETH BALYAKINA, MS, MPH, DO's NPI number?
ELIZABETH BALYAKINA, MS, MPH, DO's National Provider Identifier (NPI) is 1275073215, issued on 02/23/2017.
Does ELIZABETH BALYAKINA, MS, MPH, DO prescribe more brand-name or generic drugs?
ELIZABETH BALYAKINA, MS, MPH, DO's prescribing is 16% brand-name and 84% generic drugs by claim count, with $626K in brand drug costs.
Does ELIZABETH BALYAKINA, MS, MPH, DO prescribe opioids?
Yes, ELIZABETH BALYAKINA, MS, MPH, DO had 15 opioid claims in 2023 with an opioid prescribing rate of 0.4%.
How many Neuromusculoskeletal Medicine & OMM Physician providers are there in the US?
There are 1,235 Neuromusculoskeletal Medicine & OMM Physician providers across 51 states in the US. The average Neuromusculoskeletal Medicine & OMM Physician provider writes 1,107 Medicare Part D claims per year.
What drugs does ELIZABETH BALYAKINA, MS, MPH, DO prescribe most often?
Based on 2023 Medicare Part D data, ELIZABETH BALYAKINA, MS, MPH, DO's most frequently prescribed drugs include Atorvastatin Calcium, Fluticasone Propionate, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ELIZABETH BALYAKINA, MS, MPH, DO accept Medicare?
ELIZABETH BALYAKINA, MS, MPH, DO appears in CMS Medicare data with 4,122 Part D claims and 351 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ELIZABETH BALYAKINA, MS, MPH, DO's credentials?
ELIZABETH BALYAKINA, MS, MPH, DO's NPI is 1275073215 with credentials MS, MPH, DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology